Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19

Catherine E Oldenburg^{1

2

3}, Thuy Doan^{2

1}

Affiliations

¹ Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
² Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.

Editorial

Catherine E Oldenburg et al. Am J Trop Med Hyg. 2020 Jun.

. 2020 Jun;102(6):1154-1155.

doi: 10.4269/ajtmh.20-0262.

Catherine E Oldenburg^{1

2

3}, Thuy Doan^{2

1}

¹ Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
² Francis I. Proctor Foundation, University of California, San Francisco, San Francisco, California.
³ Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.

No abstract available

Conflict of interest statement

Financial support: C. E. O. and T. D. are supported by Career Development Awards from Research to Prevent Blindness.

Disclaimer: The funder had no role in the conception or writing of the manuscript or the decision to submit it for publication.

1. Gautret P, et al. 2020. Hydroxychloroquine and azithromycin as treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. Epub ahead. 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed
1. Lim J, Jeon S, Shin H, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ, 2020. Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35: 1–6. - PubMed
1. Cao B, et al. 2020. A trial of lopinavir–ritonavir in adults hospitalized with severe covid-19. N Engl J Med. Epub ahead of print. - PMC - PubMed
1. Berry SM, et al. 2017. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatmetns: a model for pandemic response. Clin Trials 13: 22–30. - PMC - PubMed
1. Iwuji CC, et al. 2018. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 5 e116–e125. - PubMed